Exon 3 insert of tau protein in neurodegenerative diseases

Seishi Terada, Hideki Ishizu, Koichi Ishiguro, Yasuyuki Tanabe, Nobuo Itoh, Kaori Yasutake, Akiko Furubayashi, Yoshihiro Kitamura, Shigetoshi Kuroda

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Microtubule-associated protein tau is the major component of the filamentous neurofibrillary lesions of Alzheimer's disease (AD) and other tauopathies. Recently, it has been reported that tau isoforms lacking both N-terminal exon 2 and exon 3 do not form straight filament- or paired helical filament-like filaments in vitro, and that the N-terminal exons facilitate assembly of full-length tau. However, neuropathological and biological studies on the N-terminal region of tau protein in human tissue have been limited. We performed a biochemical study on the abnormally phosphorylated tau in brains affected by AD and corticobasal degeneration (CBD), and an immunohistochemical study on tau-positive structures in neurodegenerative diseases, to clarify whether tau with the exon 3 insert was present in abnormal tau-positive structures. On immunoblots of sarkosyl-insoluble tau, anti-exon 3 antibody (anti-E3 Ab) recognized two bands of 68 and 72 kDa in AD and only one band of 72 kDa in CBD. Immunohistochemically, anti-E3 Ab recognized most parts of the neurofibrillary tangles (NFT) in AD and Pick bodies in Pick's disease. In progressive supranuclear palsy (PSP) and CBD, most NFT and pretangles were positive for anti-E3 Ab, as were a small number of glial inclusions. These results indicate that abnormally phosphorylated tau containing the exon 3 insert is present in both PSP and CBD brain, and that CBD cannot be distinguished from PSP by immunoreactivity for anti-E3 Ab. Although most intraglial inclusions were negative for anti-E3 Ab, a few were positive. Therefore, tau isoforms containing the exon 3 insert are expressed at low levels in glial cells.

Original languageEnglish
Pages (from-to)12-18
Number of pages7
JournalActa Neuropathologica
Volume110
Issue number1
DOIs
Publication statusPublished - Jul 2005

Fingerprint

tau Proteins
Neurodegenerative Diseases
Exons
Progressive Supranuclear Palsy
Alzheimer Disease
Neurofibrillary Tangles
Antibodies
Neuroglia
Protein Isoforms
Pick Disease of the Brain
Tauopathies
Microtubule-Associated Proteins
Brain

Keywords

  • Alzheimer's disease
  • Corticobasal degeneration
  • Exon 3
  • Progressive supranuclear palsy
  • Tau

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Terada, S., Ishizu, H., Ishiguro, K., Tanabe, Y., Itoh, N., Yasutake, K., ... Kuroda, S. (2005). Exon 3 insert of tau protein in neurodegenerative diseases. Acta Neuropathologica, 110(1), 12-18. https://doi.org/10.1007/s00401-005-1012-x

Exon 3 insert of tau protein in neurodegenerative diseases. / Terada, Seishi; Ishizu, Hideki; Ishiguro, Koichi; Tanabe, Yasuyuki; Itoh, Nobuo; Yasutake, Kaori; Furubayashi, Akiko; Kitamura, Yoshihiro; Kuroda, Shigetoshi.

In: Acta Neuropathologica, Vol. 110, No. 1, 07.2005, p. 12-18.

Research output: Contribution to journalArticle

Terada, S, Ishizu, H, Ishiguro, K, Tanabe, Y, Itoh, N, Yasutake, K, Furubayashi, A, Kitamura, Y & Kuroda, S 2005, 'Exon 3 insert of tau protein in neurodegenerative diseases', Acta Neuropathologica, vol. 110, no. 1, pp. 12-18. https://doi.org/10.1007/s00401-005-1012-x
Terada S, Ishizu H, Ishiguro K, Tanabe Y, Itoh N, Yasutake K et al. Exon 3 insert of tau protein in neurodegenerative diseases. Acta Neuropathologica. 2005 Jul;110(1):12-18. https://doi.org/10.1007/s00401-005-1012-x
Terada, Seishi ; Ishizu, Hideki ; Ishiguro, Koichi ; Tanabe, Yasuyuki ; Itoh, Nobuo ; Yasutake, Kaori ; Furubayashi, Akiko ; Kitamura, Yoshihiro ; Kuroda, Shigetoshi. / Exon 3 insert of tau protein in neurodegenerative diseases. In: Acta Neuropathologica. 2005 ; Vol. 110, No. 1. pp. 12-18.
@article{e867d687116542e396b7f18573db9945,
title = "Exon 3 insert of tau protein in neurodegenerative diseases",
abstract = "Microtubule-associated protein tau is the major component of the filamentous neurofibrillary lesions of Alzheimer's disease (AD) and other tauopathies. Recently, it has been reported that tau isoforms lacking both N-terminal exon 2 and exon 3 do not form straight filament- or paired helical filament-like filaments in vitro, and that the N-terminal exons facilitate assembly of full-length tau. However, neuropathological and biological studies on the N-terminal region of tau protein in human tissue have been limited. We performed a biochemical study on the abnormally phosphorylated tau in brains affected by AD and corticobasal degeneration (CBD), and an immunohistochemical study on tau-positive structures in neurodegenerative diseases, to clarify whether tau with the exon 3 insert was present in abnormal tau-positive structures. On immunoblots of sarkosyl-insoluble tau, anti-exon 3 antibody (anti-E3 Ab) recognized two bands of 68 and 72 kDa in AD and only one band of 72 kDa in CBD. Immunohistochemically, anti-E3 Ab recognized most parts of the neurofibrillary tangles (NFT) in AD and Pick bodies in Pick's disease. In progressive supranuclear palsy (PSP) and CBD, most NFT and pretangles were positive for anti-E3 Ab, as were a small number of glial inclusions. These results indicate that abnormally phosphorylated tau containing the exon 3 insert is present in both PSP and CBD brain, and that CBD cannot be distinguished from PSP by immunoreactivity for anti-E3 Ab. Although most intraglial inclusions were negative for anti-E3 Ab, a few were positive. Therefore, tau isoforms containing the exon 3 insert are expressed at low levels in glial cells.",
keywords = "Alzheimer's disease, Corticobasal degeneration, Exon 3, Progressive supranuclear palsy, Tau",
author = "Seishi Terada and Hideki Ishizu and Koichi Ishiguro and Yasuyuki Tanabe and Nobuo Itoh and Kaori Yasutake and Akiko Furubayashi and Yoshihiro Kitamura and Shigetoshi Kuroda",
year = "2005",
month = "7",
doi = "10.1007/s00401-005-1012-x",
language = "English",
volume = "110",
pages = "12--18",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Exon 3 insert of tau protein in neurodegenerative diseases

AU - Terada, Seishi

AU - Ishizu, Hideki

AU - Ishiguro, Koichi

AU - Tanabe, Yasuyuki

AU - Itoh, Nobuo

AU - Yasutake, Kaori

AU - Furubayashi, Akiko

AU - Kitamura, Yoshihiro

AU - Kuroda, Shigetoshi

PY - 2005/7

Y1 - 2005/7

N2 - Microtubule-associated protein tau is the major component of the filamentous neurofibrillary lesions of Alzheimer's disease (AD) and other tauopathies. Recently, it has been reported that tau isoforms lacking both N-terminal exon 2 and exon 3 do not form straight filament- or paired helical filament-like filaments in vitro, and that the N-terminal exons facilitate assembly of full-length tau. However, neuropathological and biological studies on the N-terminal region of tau protein in human tissue have been limited. We performed a biochemical study on the abnormally phosphorylated tau in brains affected by AD and corticobasal degeneration (CBD), and an immunohistochemical study on tau-positive structures in neurodegenerative diseases, to clarify whether tau with the exon 3 insert was present in abnormal tau-positive structures. On immunoblots of sarkosyl-insoluble tau, anti-exon 3 antibody (anti-E3 Ab) recognized two bands of 68 and 72 kDa in AD and only one band of 72 kDa in CBD. Immunohistochemically, anti-E3 Ab recognized most parts of the neurofibrillary tangles (NFT) in AD and Pick bodies in Pick's disease. In progressive supranuclear palsy (PSP) and CBD, most NFT and pretangles were positive for anti-E3 Ab, as were a small number of glial inclusions. These results indicate that abnormally phosphorylated tau containing the exon 3 insert is present in both PSP and CBD brain, and that CBD cannot be distinguished from PSP by immunoreactivity for anti-E3 Ab. Although most intraglial inclusions were negative for anti-E3 Ab, a few were positive. Therefore, tau isoforms containing the exon 3 insert are expressed at low levels in glial cells.

AB - Microtubule-associated protein tau is the major component of the filamentous neurofibrillary lesions of Alzheimer's disease (AD) and other tauopathies. Recently, it has been reported that tau isoforms lacking both N-terminal exon 2 and exon 3 do not form straight filament- or paired helical filament-like filaments in vitro, and that the N-terminal exons facilitate assembly of full-length tau. However, neuropathological and biological studies on the N-terminal region of tau protein in human tissue have been limited. We performed a biochemical study on the abnormally phosphorylated tau in brains affected by AD and corticobasal degeneration (CBD), and an immunohistochemical study on tau-positive structures in neurodegenerative diseases, to clarify whether tau with the exon 3 insert was present in abnormal tau-positive structures. On immunoblots of sarkosyl-insoluble tau, anti-exon 3 antibody (anti-E3 Ab) recognized two bands of 68 and 72 kDa in AD and only one band of 72 kDa in CBD. Immunohistochemically, anti-E3 Ab recognized most parts of the neurofibrillary tangles (NFT) in AD and Pick bodies in Pick's disease. In progressive supranuclear palsy (PSP) and CBD, most NFT and pretangles were positive for anti-E3 Ab, as were a small number of glial inclusions. These results indicate that abnormally phosphorylated tau containing the exon 3 insert is present in both PSP and CBD brain, and that CBD cannot be distinguished from PSP by immunoreactivity for anti-E3 Ab. Although most intraglial inclusions were negative for anti-E3 Ab, a few were positive. Therefore, tau isoforms containing the exon 3 insert are expressed at low levels in glial cells.

KW - Alzheimer's disease

KW - Corticobasal degeneration

KW - Exon 3

KW - Progressive supranuclear palsy

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=23644441739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644441739&partnerID=8YFLogxK

U2 - 10.1007/s00401-005-1012-x

DO - 10.1007/s00401-005-1012-x

M3 - Article

VL - 110

SP - 12

EP - 18

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 1

ER -